{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:26Z","timestamp":1761895286413},"reference-count":30,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2008]]},"DOI":"10.5551\/jat.e512","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"20-25","source":"Crossref","is-referenced-by-count":29,"title":["HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia"],"prefix":"10.5551","volume":"15","author":[{"given":"Jing-Zhi","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tamasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutaro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1496"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10852"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92521-6"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.12.3486"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shepherd J: Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes? Atheroscler Suppl, 2005; 6: 15-19","DOI":"10.1016\/j.atherosclerosissup.2005.06.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Powell E and Kroon P: LDL receptor and HMG CoA-reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in liver. J Clin Invest, 1994; 93: 2168-2174","DOI":"10.1172\/JCI117213"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Beylot M, Riou JP, Bienvenu F, and Mornex R: Increased ketonaemia in hyperthroidism: evidence for a beta-adrenergic mechanism. Diabetologia, 1980; 19: 505-510","DOI":"10.1007\/BF00253176"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00758-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Harper CR and Jacobson TA: New perspectives on the management of low levels of high-density lipoprotein cholesterol. Arch Intern Med, 1999; 159: 1049-1057","DOI":"10.1001\/archinte.159.10.1049"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-200004000-00002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Von Eckardstein A, Nofer J, and Assmann G: High density lipoproteins and arterisclerosis: Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol, 2001; 21: 13-17","DOI":"10.1161\/01.ATV.21.1.13"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/11878"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Trigatti BL, Rigotti A, and Braun A: Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochim Biophys Acta, 2000; 1529: 276-286","DOI":"10.1016\/S1388-1981(00)00154-2"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200114011"},{"issue":"11","key":"15","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1128\/MCB.19.11.7289","volume":"19","author":"SMART E J","year":"1999","ISSN":"http:\/\/id.crossref.org\/issn\/0270-7306","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fielding CJ and Fielding PE: Cholesterol and caveolae. structural and functional relationships. Biochim Biophys Acta, 2000; 1529: 210-222","DOI":"10.1016\/S1388-1981(00)00150-5"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.5551\/jat.11.110"},{"issue":"1","key":"18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat1994.3.1","volume":"3","author":"YAMASHITA S","year":"1996","ISSN":"http:\/\/id.crossref.org\/issn\/1340-3478","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gordon DJ and Rifkind BM: High-density lipoproteins-the clinical implications of recent studies. N Engl J Med, 1989; 321: 1311-1316","DOI":"10.1056\/NEJM198911093211907"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Goldbourt U, Yaaris S, and Medalie JH: Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol, 1997; 17: 107-113","DOI":"10.1161\/01.ATV.17.1.107"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hegele RA, Harris SB, Brunt JH, Young TK, Hanley AJ, and Zinman B: Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Aterosclerosis, 1999; 146: 153-160","DOI":"10.1016\/S0021-9150(99)00113-6"},{"issue":"2","key":"22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5551\/jat1994.7.59","volume":"7","author":"ZHANG B","year":"2000","ISSN":"http:\/\/id.crossref.org\/issn\/1340-3478","issn-type":"print"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.40.3.377"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) de Vries R, Groen A, Perton F, Dallinga-Thie G, van Wijland M, Dikkeschei L, Wolffenbuttel B, van Tol A, and Dullaart R: Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis, 2007; [Epub ahead of print]","DOI":"10.1016\/j.atherosclerosis.2006.12.027"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M510952200"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80213-5"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02152-X"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)00299-8"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116750"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:46:13Z","timestamp":1621536373000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/15\/1\/15_E512\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.e512","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}